Search - tctmd.com

Displaying 121 - 140 of 279

Sort: Relevancy | Date

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

Presentation TCT 2018

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou

September 21, 2018

Presentation TCT 2018

TCT-119: Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset

Presenter: Michael A. Kutcher, Tullio Palmerini, Masaru Ishida

September 21, 2018

Presentation TCT 2018

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Presenter: J. Michael Bacharach, Tony Das, Thijs Wakkie

September 21, 2018

Presentation TCT 2018

TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial

Presenter: Michael A. Kutcher, Tullio Palmerini, Norihiro Kogame

September 21, 2018

Presentation TCT 2018

TCT-117: The Burden of Restenosis after Coronary Stent Implantation in the United States: Temporal Trends, Clinical Presentation, Treatment Strategies, and In-Hospital Outcomes

Presenter: Michael A. Kutcher, Tullio Palmerini, Issam D. Moussa

September 21, 2018

Presentation TCT 2018

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Presenter: Alexandre Abizaid, Didier Carrié, David E. Kandzari

September 21, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

Presentation TCT 2018

DRAP( Distal Radial Artery Puncture): Should We Shift to It from Radial Artery?

Presenter: Lei Ge, Masahiko Ochiai, Shingo Kaneko

September 21, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2018

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Ricardo A. Costa

September 21, 2018

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Antonio L. Bartorelli, David G. Rizik, Michael Haude

September 21, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Chuck Simonton

September 21, 2018

Presentation TCT 2018

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Presenter: Runlin Gao, Martin B. Leon, Shao-Liang Chen

September 21, 2018

Presentation TCT 2018

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Presenter: Runlin Gao, Martin B. Leon, Kefei Dou

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Platforms and Outcomes 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

September 21, 2018

Advertisement

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

TCT-119: Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial

TCT-117: The Burden of Restenosis after Coronary Stent Implantation in the United States: Temporal Trends, Clinical Presentation, Treatment Strategies, and In-Hospital Outcomes

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

DRAP( Distal Radial Artery Puncture): Should We Shift to It from Radial Artery?

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

The Methods for Coronary Stent Development

The Methods for Coronary Stent Development

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content